MedPath
HSA Approval

POTASSIUM CHLORIDE INJECTION - HIGHLY CONCENTRATED (200 mEq/l)

SIN11567P

POTASSIUM CHLORIDE INJECTION - HIGHLY CONCENTRATED (200 mEq/l)

POTASSIUM CHLORIDE INJECTION - HIGHLY CONCENTRATED (200 mEq/l)

June 21, 2001

BAXTER HEALTHCARE (ASIA) PTE LTD

BAXTER HEALTHCARE (ASIA) PTE LTD

Regulatory Information

BAXTER HEALTHCARE (ASIA) PTE LTD

BAXTER HEALTHCARE (ASIA) PTE LTD

Therapeutic

General Sale List

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

B05BB01

electrolytes

Manufacturer Information

BAXTER HEALTHCARE (ASIA) PTE LTD

Baxter Healthcare Corporation

Baxter Healthcare Philippines Inc.

Active Ingredients

POTASSIUM CHLORIDE

746 mg/50 ml

Potassium chloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

POTASSIUM CHLORIDE INJECTION - HIGHLY CONCENTRATED (200 mEq/l) - HSA Approval | MedPath